ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males

Completed · Not applicable

Conditions studied: Urinary Incontinence

In brief

The purpose of the study is to evaluate the safety and effectiveness of a minimally invasive surgical procedure in up to 109 male patients. The ProACT device is designed to treat men who have stress urinary incontinence arising from intrinsic sphincter deficiency following an operation performed on the prostate for cancer or for benign prostatic hyperplasia. Two adjustable balloons (one on each side of the urethra) are implanted to treat urinary stress incontinence. The results will be analyzed to demonstrate the effects of the device as well as its associated risks. Therapeutic success will be based on whether patients demonstrate at least a 50% reduction in pad weight at 18 months follow-up compared to the pad weight results at baseline.

Key facts

Study ID

NCT00277095

Run by

Uromedica

People needed

123

Starts

2005-08-01

Expected to finish

2017-12-01

Last updated by the study team

2018-05-31

Who can join

Age: 45 and older. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Undergone either a radical prostatectomy, transurethral resection of the prostate or other prostate surgery at least 12 months prior without radiation therapy
• Demonstrate primary stress urinary incontinence
• Male subjects at least 45 years of age
• Willing and able to undergo surgical implantation of the ProACT devices
• Willing and able to comply with the follow-up requirements
• Willing and able to forego any other surgical urinary incontinence treatments while participating in the study
• Willing and able to sign the informed consent
• Positive 24 hour pad weight tests (greater than or equal to 8 gram pad weight increase demonstrated in two 24-hour pad weight tests)
• Experiences at least 3 incontinence episodes per day during two baseline voiding diaries.
• Negative Urine culture
• No recurrent stricture at the anastamosis
• No known urogenital malignancy other than previously treated prostate cancer
• Physician determines subject to be suitable surgical candidate

You may not qualify if…

• Primarily Urge incontinence
• Detrusor instability or over-activity
• Residual volume greater that 100 ml or greater than 25% of the total bladder capacity after voiding.
• Subject has/had or is suspected of having bladder cancer
• History of recurrent bladder stones
• Neurogenic bladder that is atonic or has detrusor sphincter dyssynergia
• Known hemophilia or a bleeding disorder
• Abnormal PSA (Prostate Specific Antigen), according to sites laboratory standards, unless further investigation confirms no underlying prostate malignancy.
• Known sever contrast solution allergy
• Has a genitourinary mechanical prosthesis other than previous sling procedure (e.g., Artificial Urinary sphincter, implantable penile prosthesis)
• Has a urethral stricture that prevents passage of an 18 F cystoscope or has had more than one urethrotomy
• Undergone bulking procedure within 6 months of the baseline assessment
• Subject is currently enrolled or plans to enroll in another device or drug clinical trial.
• Subject is currently using an indwelling catheter or condom catheter for treatment of incontinence and is not willing to discontinue use at least 4 weeks prior to baseline assessment.

Where it is running

• University of Arizona — Tucson, Arizona, United States
• Kaiser Permanente-Los Angeles — Los Angeles, California, United States
• The Pelvic Clinic — Pembroke Pines, Florida, United States
• Indian River Urology — Vero Beach, Florida, United States
• Urological Surgeons — Kankakee, Illinois, United States
• Metro Urology — Saint Paul, Minnesota, United States
• Kansas City Urology Care — Kansas City, Missouri, United States
• Can-Med Clinical Research Inc. — Victoria, British Columbia, Canada
• CHUS-Fleurimont — Fleurimont, Quebec, Canada
• Urology Bay of Plenty (formerly Promed Urology) — Tauranga, New Zealand

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.